Outcomes of surgical decompression in patients with very severe degenerative cervical myelopathy

Branko Kopjar, Parker E. Bohm, Joshua H. Arnold, Michael G. Fehlings, Lindsay A. Tetreault, Paul M Arnold

Research output: Contribution to journalReview article

Abstract

Study Design. A prospective observational international study. Objective. The aim of this study was to evaluate outcomes of decompressive surgery in patients with very severe degenerative cervical myelopathy (DCM). Summary of Background Data. Although decompressive surgery has been evidenced as a safe and effective approach for patients with myelopathic deficiencies, studies have suggested residual disability following treatment in patients with more severe disease presentation. Methods. Postoperative outcomes of 60 patients with very severe DCM (modified Japanese Orthopaedic Association [mJOA] score ≤8) were compared to outcomes of 188 patients with severe DCM (mJOA 9-11). Postimputation follow-up rate was 93.1%. Unadjusted and adjusted analyses were performed using two-way repeated measures of covariance. Results. The two cohorts were similar in demographics, length of duration of myelopathy symptoms, source of stenosis, and surgical approaches used to decompress the spine. The very severe and severe cohorts differed in preoperative Nurick grades (4.97 vs. 3.91, respectively, P<0.0001) and Neck Disability Index scores (45.20 vs. 56.21, respectively, P=0.0006). There were no differences in Short Form 36 (SF-36v2) physical (PCS) and mental (MCS) component summary scores. Both cohorts improved in mJOA, Nurick, Neck Disability Index, and SF-36v2 PCS and MCS scores. Despite the substantial postoperative improvements, patients in both cohorts had considerable residual symptoms. Two-Thirds of the patients in the very severe cohort had severe (mJOA -11) or moderate (mJOA ≤ 14) myelopathy symptoms at 24 months follow-up. Longer duration of disease was associated with poorer treatment response. Conclusion. Decompressive surgery is effective in patients with very severe DCM; however, patients have significant residual symptoms and disability. The very severe subgroup (mJOA 8) of patients with DCM represents a distinct group of patients and their different clinical trajectory is important for clinicians and patients to recognize. Duration of symptoms negatively affects chances for recovery. Whenever possible, patients with DCM should be treated before developing very severe symptomatology.

Original languageEnglish (US)
Pages (from-to)1102-1109
Number of pages8
JournalSpine
Volume43
Issue number16
DOIs
StatePublished - Jan 1 2018

Fingerprint

Surgical Decompression
Spinal Cord Diseases
Orthopedics
Neck
Observational Studies

Keywords

  • Cervical spondylotic myelopathy
  • Degenerative cervical myelopathy
  • Severe myelopathy
  • Surgical treatment.

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Clinical Neurology

Cite this

Outcomes of surgical decompression in patients with very severe degenerative cervical myelopathy. / Kopjar, Branko; Bohm, Parker E.; Arnold, Joshua H.; Fehlings, Michael G.; Tetreault, Lindsay A.; Arnold, Paul M.

In: Spine, Vol. 43, No. 16, 01.01.2018, p. 1102-1109.

Research output: Contribution to journalReview article

Kopjar, Branko ; Bohm, Parker E. ; Arnold, Joshua H. ; Fehlings, Michael G. ; Tetreault, Lindsay A. ; Arnold, Paul M. / Outcomes of surgical decompression in patients with very severe degenerative cervical myelopathy. In: Spine. 2018 ; Vol. 43, No. 16. pp. 1102-1109.
@article{a459af19f9944c2abead8e7449dd9e6c,
title = "Outcomes of surgical decompression in patients with very severe degenerative cervical myelopathy",
abstract = "Study Design. A prospective observational international study. Objective. The aim of this study was to evaluate outcomes of decompressive surgery in patients with very severe degenerative cervical myelopathy (DCM). Summary of Background Data. Although decompressive surgery has been evidenced as a safe and effective approach for patients with myelopathic deficiencies, studies have suggested residual disability following treatment in patients with more severe disease presentation. Methods. Postoperative outcomes of 60 patients with very severe DCM (modified Japanese Orthopaedic Association [mJOA] score ≤8) were compared to outcomes of 188 patients with severe DCM (mJOA 9-11). Postimputation follow-up rate was 93.1{\%}. Unadjusted and adjusted analyses were performed using two-way repeated measures of covariance. Results. The two cohorts were similar in demographics, length of duration of myelopathy symptoms, source of stenosis, and surgical approaches used to decompress the spine. The very severe and severe cohorts differed in preoperative Nurick grades (4.97 vs. 3.91, respectively, P<0.0001) and Neck Disability Index scores (45.20 vs. 56.21, respectively, P=0.0006). There were no differences in Short Form 36 (SF-36v2) physical (PCS) and mental (MCS) component summary scores. Both cohorts improved in mJOA, Nurick, Neck Disability Index, and SF-36v2 PCS and MCS scores. Despite the substantial postoperative improvements, patients in both cohorts had considerable residual symptoms. Two-Thirds of the patients in the very severe cohort had severe (mJOA -11) or moderate (mJOA ≤ 14) myelopathy symptoms at 24 months follow-up. Longer duration of disease was associated with poorer treatment response. Conclusion. Decompressive surgery is effective in patients with very severe DCM; however, patients have significant residual symptoms and disability. The very severe subgroup (mJOA 8) of patients with DCM represents a distinct group of patients and their different clinical trajectory is important for clinicians and patients to recognize. Duration of symptoms negatively affects chances for recovery. Whenever possible, patients with DCM should be treated before developing very severe symptomatology.",
keywords = "Cervical spondylotic myelopathy, Degenerative cervical myelopathy, Severe myelopathy, Surgical treatment.",
author = "Branko Kopjar and Bohm, {Parker E.} and Arnold, {Joshua H.} and Fehlings, {Michael G.} and Tetreault, {Lindsay A.} and Arnold, {Paul M}",
year = "2018",
month = "1",
day = "1",
doi = "10.1097/BRS.0000000000002602",
language = "English (US)",
volume = "43",
pages = "1102--1109",
journal = "Spine",
issn = "0362-2436",
publisher = "Lippincott Williams and Wilkins",
number = "16",

}

TY - JOUR

T1 - Outcomes of surgical decompression in patients with very severe degenerative cervical myelopathy

AU - Kopjar, Branko

AU - Bohm, Parker E.

AU - Arnold, Joshua H.

AU - Fehlings, Michael G.

AU - Tetreault, Lindsay A.

AU - Arnold, Paul M

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Study Design. A prospective observational international study. Objective. The aim of this study was to evaluate outcomes of decompressive surgery in patients with very severe degenerative cervical myelopathy (DCM). Summary of Background Data. Although decompressive surgery has been evidenced as a safe and effective approach for patients with myelopathic deficiencies, studies have suggested residual disability following treatment in patients with more severe disease presentation. Methods. Postoperative outcomes of 60 patients with very severe DCM (modified Japanese Orthopaedic Association [mJOA] score ≤8) were compared to outcomes of 188 patients with severe DCM (mJOA 9-11). Postimputation follow-up rate was 93.1%. Unadjusted and adjusted analyses were performed using two-way repeated measures of covariance. Results. The two cohorts were similar in demographics, length of duration of myelopathy symptoms, source of stenosis, and surgical approaches used to decompress the spine. The very severe and severe cohorts differed in preoperative Nurick grades (4.97 vs. 3.91, respectively, P<0.0001) and Neck Disability Index scores (45.20 vs. 56.21, respectively, P=0.0006). There were no differences in Short Form 36 (SF-36v2) physical (PCS) and mental (MCS) component summary scores. Both cohorts improved in mJOA, Nurick, Neck Disability Index, and SF-36v2 PCS and MCS scores. Despite the substantial postoperative improvements, patients in both cohorts had considerable residual symptoms. Two-Thirds of the patients in the very severe cohort had severe (mJOA -11) or moderate (mJOA ≤ 14) myelopathy symptoms at 24 months follow-up. Longer duration of disease was associated with poorer treatment response. Conclusion. Decompressive surgery is effective in patients with very severe DCM; however, patients have significant residual symptoms and disability. The very severe subgroup (mJOA 8) of patients with DCM represents a distinct group of patients and their different clinical trajectory is important for clinicians and patients to recognize. Duration of symptoms negatively affects chances for recovery. Whenever possible, patients with DCM should be treated before developing very severe symptomatology.

AB - Study Design. A prospective observational international study. Objective. The aim of this study was to evaluate outcomes of decompressive surgery in patients with very severe degenerative cervical myelopathy (DCM). Summary of Background Data. Although decompressive surgery has been evidenced as a safe and effective approach for patients with myelopathic deficiencies, studies have suggested residual disability following treatment in patients with more severe disease presentation. Methods. Postoperative outcomes of 60 patients with very severe DCM (modified Japanese Orthopaedic Association [mJOA] score ≤8) were compared to outcomes of 188 patients with severe DCM (mJOA 9-11). Postimputation follow-up rate was 93.1%. Unadjusted and adjusted analyses were performed using two-way repeated measures of covariance. Results. The two cohorts were similar in demographics, length of duration of myelopathy symptoms, source of stenosis, and surgical approaches used to decompress the spine. The very severe and severe cohorts differed in preoperative Nurick grades (4.97 vs. 3.91, respectively, P<0.0001) and Neck Disability Index scores (45.20 vs. 56.21, respectively, P=0.0006). There were no differences in Short Form 36 (SF-36v2) physical (PCS) and mental (MCS) component summary scores. Both cohorts improved in mJOA, Nurick, Neck Disability Index, and SF-36v2 PCS and MCS scores. Despite the substantial postoperative improvements, patients in both cohorts had considerable residual symptoms. Two-Thirds of the patients in the very severe cohort had severe (mJOA -11) or moderate (mJOA ≤ 14) myelopathy symptoms at 24 months follow-up. Longer duration of disease was associated with poorer treatment response. Conclusion. Decompressive surgery is effective in patients with very severe DCM; however, patients have significant residual symptoms and disability. The very severe subgroup (mJOA 8) of patients with DCM represents a distinct group of patients and their different clinical trajectory is important for clinicians and patients to recognize. Duration of symptoms negatively affects chances for recovery. Whenever possible, patients with DCM should be treated before developing very severe symptomatology.

KW - Cervical spondylotic myelopathy

KW - Degenerative cervical myelopathy

KW - Severe myelopathy

KW - Surgical treatment.

UR - http://www.scopus.com/inward/record.url?scp=85059797994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059797994&partnerID=8YFLogxK

U2 - 10.1097/BRS.0000000000002602

DO - 10.1097/BRS.0000000000002602

M3 - Review article

C2 - 29462066

AN - SCOPUS:85059797994

VL - 43

SP - 1102

EP - 1109

JO - Spine

JF - Spine

SN - 0362-2436

IS - 16

ER -